Search for: "AbbVie, Inc." Results 61 - 80 of 146
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jun 2018, 3:08 am by Brian Cordery
Brian Corderyby Craig Lumb After a decade-long hiatus, so-called Arrow declarations are now firmly back in fashion after the Court of Appeal’s judgment last year in Fujifilm Kyowa Kirin Biologics Co, Ltd v Abbvie Biotechnology Ltd & Anor [2017] EWCA Civ 1. [read post]
25 May 2018, 9:27 am
The case of Edwards Lifesciences LLC v Boston Scientific Scimed Inc & Ors [2018] EWHC 1256 (Pat) handed down yesterday, is a little more nuanced. [read post]
9 Feb 2018, 5:15 am by Robert Schaffer
The Federal circuit heard the case on AbbVie Inc. v. [read post]
5 Feb 2018, 11:16 am by Lawrence B. Ebert
In a case related to Humica, the CAFC affirmed ED Va:AbbVie, Inc., and AbbVie Biotechnology Ltd. [read post]
17 Nov 2017, 7:44 am by Robert Kraft
District Court for the Northern District of Illinois jury ordered pharmaceutical manufacturer AbbVie Inc. to pay $150 million in damages to Oregon resident Jesse Mitchell after he filed a suit claiming the company’s AndroGel product led to a heart attack in 2012. [read post]
10 Oct 2017, 12:20 pm by Clay Hodges
Last Thursday a jury in Chicago found that AbbVie, Inc., the manufacturers of the testosterone product Androgel, must pay the plaintiff, Jeffrey Konrad, over $140,000,000.00 for injuries he suffered after using the company’s testosterone product. [read post]
4 Aug 2017, 9:40 am by Clay Hodges
Still, on balance, it must be viewed as a win for plaintiffs, and a major rebuke for companies like AbbVie, Inc. who aggressively market their prescription drugs for off-label uses. [read post]
14 Jul 2017, 9:42 am by Clay Hodges
AbbVie Inc. (1:14-cv-09178)  In 2007 Jesse Mitchell visited his doctor complaining of a constellation of symptoms, including fatigue and depression. [read post]
30 Apr 2017, 4:30 am
 Fujifilm v AbbVie: practice, procedure and policy analysisGuest Kat Eibhlin Vardy summarizes the Rapid Response event organized by AIPPI on the case Fujifilm Kyowa Kirin Biologics Company Limited v AbbVie Biotechnology Limited, [2017] EWHC 395 (Pat), from the perspective of patent and competition law.Overturning a trade mark opposition decision - Part 2 - SOULUXE - likelihood of confusionGuest Kat Rosie Burbidge recaps the case SoulCycle Inc v Matalan Ltd, [2017]… [read post]
13 Jan 2017, 9:24 am
Inc. [2007] EWHC 1900 (Pat), which settled before trial. [read post]
22 Oct 2016, 9:30 pm by Patent Docs
Natco Pharma Ltd. -- AbbVie Inc. v. [read post]